News on TELOON SOFT STRATEGY LTD from BioPortfolio.com http://www.BioPortfolio.com Consolidated TELOON SOFT STRATEGY LTD news from BioPortfolio.com Wed, 10 Feb 2010 10:02:40 GMT en Medical News: Novus Scientific Receives FDA Clearance For TIGR(TM) Matrix Surgical Mesh World's 1st Long-Term Resorbable Synthetic Meshhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025161&HITNO=0&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025161&THISHREF=http://c.moreover.com/click/here.pl%3fz2529465607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025161&HITNO=0&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025161&THISHREF=http://c.moreover.com/click/here.pl%3fz2529465607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Novus Scientific Receives FDA Clearance For TIGR(TM) Matrix Surgical Mesh World's 1st Long-Term Resorbable Synhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024926&HITNO=1&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024926&THISHREF=http://c.moreover.com/click/here.pl%3fz2529261182%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024926&HITNO=1&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024926&THISHREF=http://c.moreover.com/click/here.pl%3fz2529261182%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Novus Scientific's TIGR Matrix Surgical Mesh receives FDA marketing approvalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024413&HITNO=2&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024413&THISHREF=http://c.moreover.com/click/here.pl%3fz2528872890%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024413&HITNO=2&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024413&THISHREF=http://c.moreover.com/click/here.pl%3fz2528872890%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - World's 1st Long-Term Resorbable Shttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024143&HITNO=3&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024143&THISHREF=http://c.moreover.com/click/here.pl%3fz2528659153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024143&HITNO=3&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024143&THISHREF=http://c.moreover.com/click/here.pl%3fz2528659153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: 2/5/10 - Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - World's 1st Long-Term Reshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023919&HITNO=4&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023919&THISHREF=http://c.moreover.com/click/here.pl%3fz2528487232%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023919&HITNO=4&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023919&THISHREF=http://c.moreover.com/click/here.pl%3fz2528487232%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Market tumble raises questions over Asia's outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020991&HITNO=5&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020991&THISHREF=http://c.moreover.com/click/here.pl%3fz2527084166%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020991&HITNO=5&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020991&THISHREF=http://c.moreover.com/click/here.pl%3fz2527084166%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - World's 1st Long-Term Resorbable Synthetic Meshhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022218&HITNO=6&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022218&THISHREF=http://c.moreover.com/click/here.pl%3fz2527555943%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022218&HITNO=6&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022218&THISHREF=http://c.moreover.com/click/here.pl%3fz2527555943%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Biomarkers in Drug Development: A Handbook of Practice, Application, and Strategyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996624&HITNO=7&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996624&THISHREF=http://c.moreover.com/click/here.pl%3fz2516388339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996624&HITNO=7&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996624&THISHREF=http://c.moreover.com/click/here.pl%3fz2516388339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Basilea reports 2009 financial resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989717&HITNO=8&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989717&THISHREF=http://c.moreover.com/click/here.pl%3fz2512807719%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989717&HITNO=8&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989717&THISHREF=http://c.moreover.com/click/here.pl%3fz2512807719%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketwire via Yahoo!: Overview of biomarkers and their role in drug developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987567&HITNO=9&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987567&THISHREF=http://c.moreover.com/click/here.pl%3fz2509960357%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987567&HITNO=9&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987567&THISHREF=http://c.moreover.com/click/here.pl%3fz2509960357%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Comprehensive review of MRSA infectionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987486&HITNO=10&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987486&THISHREF=http://c.moreover.com/click/here.pl%3fz2509923373%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987486&HITNO=10&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987486&THISHREF=http://c.moreover.com/click/here.pl%3fz2509923373%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Research and Markets: Biomarkers in Drug Development: A Handbook of Practice, Application, and Strategyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986122&HITNO=11&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986122&THISHREF=http://c.moreover.com/click/here.pl%3fz2508947518%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986122&HITNO=11&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986122&THISHREF=http://c.moreover.com/click/here.pl%3fz2508947518%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Research and Markets: Staphylococci in Human Disease, 2nd Editionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980518&HITNO=12&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980518&THISHREF=http://c.moreover.com/click/here.pl%3fz2506439755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980518&HITNO=12&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980518&THISHREF=http://c.moreover.com/click/here.pl%3fz2506439755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Tyco International reports $0.63 in diluted EPS from continuing operations for fiscal first-quarter of 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975274&HITNO=13&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975274&THISHREF=http://c.moreover.com/click/here.pl%3fz2503978483%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975274&HITNO=13&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975274&THISHREF=http://c.moreover.com/click/here.pl%3fz2503978483%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Todays Zacks Rank Growth and Income Buy: Teva Pharmaceuticalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972564&HITNO=14&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972564&THISHREF=http://c.moreover.com/click/here.pl%3fz2502474223%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972564&HITNO=14&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TELOON%20SOFT%20STRATEGY%20LTD&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972564&THISHREF=http://c.moreover.com/click/here.pl%3fz2502474223%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZacks.com: